Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:10 pm Sale |
2021-12-31 | 13G | Exagen Inc. XGN |
TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,868,139 11.560% |
-22,383 (-1.18%) |
Filing History |
| 2022-02-14 08:56 am Sale |
2021-12-31 | 13G | Exagen Inc. XGN |
RTW Investments, LP | 821,414 5.100% |
-428,717 (-34.29%) |
Filing History |
| 2022-02-11 7:26 pm Purchase |
2021-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 858,567 5.300% |
25,030 (+3.00%) |
Filing History |
| 2022-02-11 2:09 pm Sale |
2022-02-11 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,105,760 6.800% |
-585,747 (-34.63%) |
Filing History |
| 2022-02-10 4:15 pm Unchanged |
2021-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 14.280% |
0 (Unchanged) |
Filing History |
| 2022-02-08 4:10 pm Sale |
2021-12-31 | 13G | Exagen Inc. XGN |
Hunt Holdings Limited Partnership | 1,011,324 6.260% |
-248,350 (-19.72%) |
Filing History |
| 2022-01-20 10:46 am Unchanged |
2021-12-31 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 1,384,631 8.570% |
0 (Unchanged) |
Filing History |
| 2022-01-19 4:21 pm Purchase |
2021-12-31 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 1,384,631 8.570% |
511,000 (+58.49%) |
Filing History |
| 2021-12-23 5:33 pm Purchase |
2021-12-20 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 833,537 5.200% |
833,537 (New Position) |
Filing History |
| 2021-12-17 3:57 pm Purchase |
2021-09-10 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 873,631 5.410% |
873,631 (New Position) |
Filing History |
| 2021-04-09 2:00 pm Purchase |
2021-04-09 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,691,507 10.000% |
647,104 (+61.96%) |
Filing History |
| 2021-02-24 4:32 pm Purchase |
2019-09-23 | 13D | Exagen Inc. XGN |
H.I.G. Bio-Exagen L.P. | 1,696,252 13.400% |
1,696,252 (New Position) |
Filing History |
| 2021-02-16 10:22 am Sale |
2020-12-31 | 13G | Exagen Inc. XGN |
Hunt Holdings Limited Partnership | 1,259,674 9.900% |
-219,141 (-14.82%) |
Filing History |
| 2021-02-16 06:21 am Sale |
2020-12-31 | 13G | Exagen Inc. XGN |
TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,890,522 14.600% |
-243,584 (-11.41%) |
Filing History |
| 2021-02-12 09:51 am Purchase |
2021-02-12 | 13G | Exagen Inc. XGN |
RTW Investments, LP | 1,250,131 9.890% |
348,046 (+38.58%) |
Filing History |
| 2021-02-11 4:15 pm Sale |
2020-12-31 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,308,958 18.250% |
-125,000 (-5.14%) |
Filing History |
| 2021-02-11 2:47 pm Purchase |
2021-02-11 | 13G | Exagen Inc. XGN |
WASATCH ADVISORS INC | 1,044,403 8.300% |
1,044,403 (New Position) |
Filing History |
| 2020-09-18 4:46 pm Purchase |
2020-09-01 | 13G | Exagen Inc. XGN |
NMSIC Co-Investment Fund, L.P. | 2,433,958 19.260% |
2,433,958 (New Position) |
Filing History |